Volume 74, Issue 10, Pages (November 2008)

Slides:



Advertisements
Similar presentations
M. Mizobuchi, J.L. Finch, D.R. Martin, E. Slatopolsky 
Advertisements

Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure  William C. Wolf, Hideaki.
Volume 60, Issue 6, Pages (December 2001)
Volume 82, Issue 1, Pages (July 2012)
Volume 75, Issue 12, Pages (June 2009)
Sodium thiosulfate prevents vascular calcifications in uremic rats
Volume 60, Issue 6, Pages (December 2001)
Volume 88, Issue 4, Pages (October 2015)
Volume 83, Issue 5, Pages (May 2013)
Volume 67, Issue 6, Pages (June 2005)
Volume 80, Issue 7, Pages (October 2011)
Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model  Jianping Dai, MD, PhD, Liliane.
Uremia-related vascular calcification: More than apatite deposition
Volume 69, Issue 8, Pages (April 2006)
Volume 67, Issue 2, Pages (February 2005)
Breast arterial calcification in chronic kidney disease: absence of smooth muscle apoptosis and osteogenic transdifferentiation  W. Charles O'Neill, Amy.
Volume 55, Issue 5, Pages (May 1999)
Volume 85, Issue 5, Pages (May 2014)
Exaggerated inflammatory environment decreases BMP-2/ACS-induced ectopic bone mass in a rat model: implications for clinical use of BMP-2  R.-L. Huang,
Volume 75, Issue 10, Pages (May 2009)
Volume 92, Issue 1, Pages (July 2017)
Mechanisms of the proteinuria induced by Rho GTPases
Neal X. Chen, Kalisha D. O'Neill, Danxia Duan, Sharon M. Moe 
Volume 82, Issue 12, Pages (December 2012)
Volume 75, Issue 9, Pages (May 2009)
Volume 60, Issue 6, Pages (December 2001)
Volume 61, Issue 2, Pages (February 2002)
Vascular calcification is dependent on plasma levels of pyrophosphate
Volume 59, Issue 4, Pages (April 2001)
Volume 83, Issue 6, Pages (June 2013)
Volume 64, Issue 2, Pages (August 2003)
Hiroyuki Yanagisawa, Nobuyuki Yamazaki, Gen Sato, Osamu Wada 
Left ventricular hypertrophy in renal failure
Hsueh Yang, Gabrielle Curinga, Cecilia M. Giachelli 
Aberrant Mineralization of Connective Tissues in a Mouse Model of Pseudoxanthoma Elasticum: Systemic and Local Regulatory Factors  Qiujie Jiang, Qiaoli.
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Volume 85, Issue 1, Pages (January 2014)
Volume 82, Issue 8, Pages (October 2012)
Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure  William C. Wolf, Hideaki.
Metabolic acidosis inhibits soft tissue calcification in uremic rats
Volume 55, Issue 2, Pages (February 1999)
Volume 69, Issue 3, Pages (February 2006)
E. Neven, S. Dauwe, M.E. De Broe, P.C. D'Haese, V. Persy 
Neil J. Paloian, Elizabeth M. Leaf, Cecilia M. Giachelli 
Role of vitamin D receptor activators on cardiovascular risk
Volume 78, Issue 8, Pages (October 2010)
M. Mizobuchi, J.L. Finch, D.R. Martin, E. Slatopolsky 
Induction of heat shock protein 70 inhibits ischemic renal injury
Volume 74, Issue 1, Pages (July 2008)
Volume 70, Issue 6, Pages (September 2006)
Volume 70, Issue 5, Pages (September 2006)
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 81, Issue 3, Pages (February 2012)
Treatment with pyrophosphate inhibits uremic vascular calcification
Nanocrystals seed calcification in more ways than one
The vascular secret of Klotho
Volume 58, Issue 4, Pages (October 2000)
Pablo A. Ureña Torres, Marc De Broe  Kidney International 
Volume 56, Issue 6, Pages (December 1999)
Volume 67, Issue 6, Pages (June 2005)
Volume 74, Issue 5, Pages (September 2008)
Volume 77, Issue 5, Pages (March 2010)
Volume 72, Issue 11, Pages (December 2007)
Volume 75, Issue 5, Pages (March 2009)
Volume 74, Issue 10, Pages (November 2008)
Breast arterial calcification in chronic kidney disease: absence of smooth muscle apoptosis and osteogenic transdifferentiation  W. Charles O'Neill, Amy.
Volume 69, Issue 11, Pages (June 2006)
Volume 65, Issue 6, Pages (June 2004)
Volume 87, Issue 6, Pages (June 2015)
Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in.
Presentation transcript:

Volume 74, Issue 10, Pages 1270-1277 (November 2008) Cinacalcet suppresses calcification of the aorta and heart in uremic rats  Takehisa Kawata, Nobuo Nagano, Masaki Obi, Sonoe Miyata, Chika Koyama, Nami Kobayashi, Sachiko Wakita, Michihito Wada  Kidney International  Volume 74, Issue 10, Pages 1270-1277 (November 2008) DOI: 10.1038/ki.2008.407 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 Aortic mineral content. Thoracic–abdominal aortae were dissected and incinerated. The calcium (Ca) and phosphorus (P) content of the resulting ash samples was then measured and expressed as the weight of Ca or P per dry weight of tissue. The aortic Ca and P content was found to have increased significantly in nephrectomized (NX) rats. However, cinacalcet treatment suppressed these increases. The values shown are the mean±s.e. (n=8–12). ††P<0.01 vs the NX baseline; ##P<0.01 vs the sham-operated group; *P<0.05 vs the NX-vehicle-treated group. Kidney International 2008 74, 1270-1277DOI: (10.1038/ki.2008.407) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 2 Alizarin red staining of the aortic arch. (a) Sham-operated rat; (b) NX-vehicle-treated rat; (c) cinacalcet-treated rat (5mg/kg); (d) cinacalcet-treated rat (15mg/kg). Aortic arches were stained with alizarin red. As indicated by the red staining, the sections from nephrectomized (NX) rats showed calcification in the medial smooth muscle cells, indicating the presence of Mönckeberg-type arterial calcification. No calcium deposits were observed in the aortic tissues from animals treated with 15mg/kg cinacalcet (d) and only slight calcification was found in rats treated with 5 mg/kg cinacalcet (c) (Original magnification, × 40.) Kidney International 2008 74, 1270-1277DOI: (10.1038/ki.2008.407) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 3 Heart mineral content. Dissected hearts were incinerated, and the levels of calcium (Ca) and phosphorus (P) content were then measured as described in Figure 1. In the nephrectomized (NX)-vehicle-treated group, the heart Ca and P content increased significantly, but this increase was suppressed in both cases by cinacalcet treatment. The values shown are the mean±s.e. (n=8–12). #P<0.05; ##P<0.01 vs the sham-operated group; *P<0.05 vs the NX-vehicle-treated group. Kidney International 2008 74, 1270-1277DOI: (10.1038/ki.2008.407) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 4 Alizarin red staining of the aortic valve. Dissected aortic root tissues were stained with alizarin red. Sections from nephrectomized (NX) rats show calcification, indicated by red staining. No calcium deposits were detectable, however, in the same tissues from animals treated with cinacalcet. (a) Sham-operated rat; (b) NX-vehicle-treated rat; (c) cinacalcet-treated rat (5mg/kg); (d) cinacalcet-treated rat (15mg/kg). (Original magnification, × 40.) Kidney International 2008 74, 1270-1277DOI: (10.1038/ki.2008.407) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 5 The mRNA expression of calcification-related factors. Total RNA was isolated from rat aortae and reverse transcribed to cDNA. The cDNA was quantified for osteocalcin (OCN), osteopontin (OPN), runt-related gene 2 (Runx2), matrix Gla protein (MGP), and osteoprotegerin (OPG). The aortic mRNA expression levels of osteocalcin, osteopontin, Runx2, and MGP were increased in the NX-vehicle-treated rats compared with the sham-operated rats. Their expression levels in NX-cinacalcet-treated rats were similar to those in sham-operated rats. The values shown are the mean±s.e. (n=5). #P<0.05 vs the sham-operated group; *P<0.05 vs the NX-vehicle-treated group. Kidney International 2008 74, 1270-1277DOI: (10.1038/ki.2008.407) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 6 Osteocalcin and osteopontin protein expression in aortae. Histological sections of aortic arches were used for immunostaining of osteocalcin and osteopontin. The protein expression of both osteocalcin and osteopontin was increased in the aortae of NX-vehicle-treated rats (arrows), whereas no marked expression was observed in the aortae of NX-cinacalcet-treated rats. In each photograph, the top side is intima and the bottom side is adventitia. (Original magnification, × 400.) Kidney International 2008 74, 1270-1277DOI: (10.1038/ki.2008.407) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 7 Aortic mineral content in parathyroidectomized (PTX) rats. The calcium (Ca) and phosphorus (P) content in the aortae was found to increase significantly in nephrectomized (NX) rats; however, PTX inhibited these increases. The values shown are the mean±s.e. (n=6). #P<0.05 vs the sham-operated group; **P<0.01 vs the NX group. Kidney International 2008 74, 1270-1277DOI: (10.1038/ki.2008.407) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 8 Experimental design for the studies. Kidney International 2008 74, 1270-1277DOI: (10.1038/ki.2008.407) Copyright © 2008 International Society of Nephrology Terms and Conditions